Dicerna Pharmaceuticals Net Tangible Assets

Dicerna Pharmaceuticals (DRNA) currently reports a net tangible assets of $110M as of September 2021. That compares with $150M in the prior-year period — down 30.0% year over year. Use the charts on this page to explore Dicerna Pharmaceuticals's net tangible assets history and peer comparisons.

Dicerna Pharmaceuticals's net tangible assets decreased from $150M to $110M — a 30.0% year-over-year decrease (period ending September 2021). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Dicerna Pharmaceuticals reported $110M in net tangible assets as of September 2021. That compares with $150M in the prior-year period — down 30.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $110M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Dicerna Pharmaceuticals, and consider following DRNA for alerts when major investors trade the stock.

Dicerna Pharmaceuticals is classified in the Healthcare sector. On net tangible assets, it currently shows $110M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing DRNA with unrelated industries.